Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities

被引:0
作者
Nathan J. Lanning
Joshua P. Castle
Simar J. Singh
Andre N. Leon
Elizabeth A. Tovar
Amandeep Sanghera
Jeffrey P. MacKeigan
Fabian V. Filipp
Carrie R. Graveel
机构
[1] California State University,Systems Biology and Cancer Metabolism, Program for Quantitative Systems Biology
[2] Van Andel Research Institute,College of Human Medicine
[3] University of California Merced,undefined
[4] Michigan State University,undefined
来源
Cancer & Metabolism | / 5卷
关键词
Triple-negative breast cancer; Metabolism; Rate-limiting enzymes; Receptor tyrosine kinase; Tyrosine kinase inhibitor; Metabolic inhibitor;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 543 条
[1]  
Foulkes WD(2010)Triple-negative breast cancer N Engl J Med 363 1938-1948
[2]  
Smith IE(2007)Triple-negative breast cancer: clinical features and patterns of recurrence Clin Cancer Res 13 4429-4434
[3]  
Reis-Filho JS(2008)Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer J Clin Oncol 26 1275-1281
[4]  
Dent R(2011)Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies J Clin Invest 121 2750-2767
[5]  
Trudeau M(2015)Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer Clin Cancer Res 21 1688-1698
[6]  
Pritchard KI(1991)Epidermal growth factor receptor-negative tumors are predominantly confined to the subgroup of estradiol receptor-positive human primary breast cancers Cancer Res 51 4544-4548
[7]  
Hanna WM(1987)Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer Lancet (London, England) 1 1398-1402
[8]  
Kahn HK(1987)Biological effect of epidermal growth factor on the in vitro growth of human tumors Cancer Res 47 403-406
[9]  
Sawka CA(1991)Epidermal growth factor receptor expression as a prognostic indicator in breast cancer Eur J Cancer 27 977-980
[10]  
Lickley LA(2008)Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype Clin Cancer Res 14 1368-1376